In summary, we found that fibroblast-secreted Gal-1 significantly enhanced multiple in vitro CRC CIC properties including enhancing EMT and activating β-catenin, as well as promoting in vivo metastatic disease and tumor dissemination, and clinical recurrence. This evidence concerns the gene LGALS1 and colorectal carcinoma.